245 results about "Human digestive system" patented technology

The present invention is directed to an apparatus and method for treating obesity. A tube is positioned that passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his / her everyday affairs including ingesting food. After the patient has ingested food, the food is extracted by pumping it out of the upper digestive system through the tube. The present invention is less invasive than current surgical procedures for reducing weight and allows patients to live a normal and active lifestyle without experiencing adverse side effects.

To treat obesity, a tube is positioned so that it passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his / her everyday affairs including ingesting food. After ingestion, food is extracted by pumping it out of the upper digestive system through the tube. The embodiments described herein take advantage of some properties of ePTFE to provide a number of significant advantages.

The present invention is directed to an apparatus and method for treating obesity. A tube is positioned that passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his / her everyday affairs including ingesting food. After the patient has ingested food, the food is extracted by pumping it out of the upper digestive system through the tube. The present invention is less invasive than current surgical procedures for reducing weight and allows patients to live a normal and active lifestyle without experiencing adverse side effects.

The invention provides a method for brewing a yellow wine using enzyme preparation and multi-bacteria, characterized in that: the concrete steps are that: soaking glutinous rice in clean water and adding lipase; steaming the glutinous rice and cooling, and adding alpha-amylase and neutral protease into the mixture and incubating and liquefying the mixture; adjusting the pH of mash and adding acid-resistant glucoamylase and incubating, saccharifying and cooling the mixture; adding bran koji, saccharomyces cerivisiae, ester-producing yeast and saccharifying and fermenting the mixture until the alcohol content is 12 degrees; continuously fermenting the mixture until the alcohol content is larger than 15 degrees and squeezing and filtering the mixture; adding stachyose, oligoisomaltose, honey,medlar leach solution and lycopene antioxidant into the filtered solution; processing the above mixture using a microwave alcoholic ripening machine and adding diatomite absorbent into the mixture and quickly freezing the mixture to clarify the mixture and then using a diatomite filter machine to filter the mixture and finally using membrane micro-straining technology to strain and degerm the product. The advantages of the invention are that: the wine taste is rich and strong; the wine body is full and soft and the wine is a health-care wine capable of adjusting the micro-ecological balance of the human digestive system.

The invention relates to a biological fermentation composition with an anti-cancer effect. The biological fermentation composition is prepared by using a method comprising the following steps: a, preparing a culture medium mixed solution; b, sterilizing; c, cooling; d, inoculating to obtain a fermentation solution; and e, standing to obtain the biological fermentation composition with the anti-cancer effect. The composition disclosed by the invention can be used for improving the in-vivo micro-ecological environment, balancing and regulating effective microbial communities in intestinal canals, repairing damaged cells, replenishing various in-vivo active bio-enzymes, amino acids, nucleic acids, trace elements and the like, improving the immunity of a human body, preventing diseases, effectively inhibiting cancer cells and stopping the dispersion and development of the cancer cells. Meanwhile, the biological fermentation composition can be used for improving an acidic physique to be a weak alkaline physique, is particularly suitable for the cancer crowd, the crowd with hypertension, hyperlipidemia and hyperglycemia and the fat crowd, can be prepared into various dosage forms such as pills, paste, aqueous solutions and the like, and has favorable supportive therapeutic effects on cancer, diabetes, digestive system diseases and the like.

A method of collecting a specimen of the present invention is used in detecting upper digestive system disease. The method of collecting a specimen includes: a step of positioning sampling equipment in the duodenum of the subject into which duodenal juice is secreted, the sampling equipment being used to collect and store the duodenal juice; a step of collecting duodenal juice naturally secreted in the duodenum using the sampling equipment; and a step of stopping collection of the duodenal juice when collection quantity of the duodenal juice reaches a predetermined quantity which is 3.0 ml or less.

An object of the present invention is to provide a method for suppressing surgical site infections (SSI) that have occurred at extremely high incidence rates at the time of surgical operations and particularly surgical operations on digestive system organs, and to provide a column to be used for the method. According to the present invention, a method is provided for suppressing surgical site infections, which comprises the steps of: (a) administering a chemotherapeutic drug for treating and / or preventing a surgical site infection; and (b) collecting blood from a surgical subject and removing leukocytes that comprise neutrophils from the blood during or within 24 hours after surgical operation, and then returning the blood from which the leukocytes have been removed to the surgical subject. The present invention also provides a column for blood circulation which is filled with a carrier having affinity for leukocytes comprising neutrophils, which is used for suppressing a surgical site infection during or within 24 hours after surgical operation on a digestive system organ.

A process for preparing tetrodopeptide from the skin and / or bone of globefish includes pretreating, extracting, concentrating, drying and pulverizing. Said tetrodopeptide can be used to prepare medicines or health-care food for preventing and treating the diseases in digestive system, immunopathy and tumor.

The present invention is directed to an apparatus and method for treating obesity. An artificial obstruction is introduced into the patient's gastrointestinal tract, and a tube is positioned that passes through a patient's abdominal wall into the upper digestive system of the patient. The patient is allowed to carry out his / her everyday affairs including ingesting food. After the patient has ingested food, the food is extracted by pumping it out of the upper digestive system through the tube. The present invention is less invasive than current surgical procedures for reducing weight and allows patients to live a normal and active lifestyle without experiencing adverse side effects.

The invention belongs to the field of feed processing and particularly provides ruminant animal fat powder. The ruminant animal fat powder is prepared by matching hexadecanoic acid, high-melting-point palm oil, soybean concentrated phospholipids and the like as main fat raw materials with a carrier. The ruminant animal fat powder has no influence on normal physiological activity of microflora in ruminant animal rumen, can pass through the rumen, can be converted into an absorbed form under the actions of chemistry and enzyme in abomasums and duodenum of a digestion system and is digested, absorbed and utilized by small intestine. The product prepared by a formula and a processing technique of the invention is favorable in flowing property and can be mixed to the feed by adopting corresponding dosage stirring according to the requirement of animal nutrition; and the product is convenient and practical and is convenient for storage and transportation.

The invention discloses diet tea which is prepared from the following traditional Chinese medicine herbs in parts by weight: 50 parts of diet tea, 20 parts of cortex albiziae, 10 parts of Chinese-date, 5 parts of the fruit of Chinese wolfberry, 5 parts of white mustard seeds, 5 parts of honeysuckle, 3 parts of folium artemisiae argyi, 3 parts of dry ginger, 3 parts of hawthorn, 3 parts of myrrh, 3 parts of cynanchum glaucescens, 3 parts of semen euryales, 2 parts of red ginseng, 2 parts of Chinese violet, 2 parts of oldenlandia diffusa, 2 parts of poria cocos and 2 parts of oriental wormwood. The diet tea disclosed by the invention is safe and reliable, free of harm to human body digestive systems and absorption systems and free of toxic and side effects, can nourish qi and blood and prompt normal metabolism of human bodies, and at the same time has the effects of lowing cholesterol and blood fat; the lose weight effect is remarkable, the weight is unlikely to rebound after people stop taking the diet tea; meanwhile the raw materials of the diet tea are cheap and easy to access, so that the diet tea has the advantage of low cost, and is applicable to popularization to the market.

A method and composition prevents, controls and ameliorates urinary tract infections caused by E. coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyanidin containing concentrate, D-mannose and a proprietary probiotic blend. The cranberry derivative or proanthocyanidin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose. A proprietary probiotic blend is included to provide 5 billion CFU per dose.

The invention discloses a human intestinal tract model visible bionic digestion system which comprises a reaction system and a control system, wherein the reaction system comprises a bionic stomach system, a bionic small intestine system, a bionic large intestine system and a filtering system; the control system comprises a PLC (Programmed Logic Controller), a peristaltic pump and a circulation water tank; water inlet tubes of the bionic stomach system, the bionic small intestine system and the bionic large intestine system are connected with the water outlet of the circulation water tank; water outlet tubes of the bionic stomach system, the bionic small intestine system and the bionic large intestine system are connected with the water inlet of the circulation water tank; electromagneticvalves are arranged on the water tubes; the PLC is used for controlling the electromagnetic valves on the water tubes. The bionic digestion system disclosed by the invention is good in visibility, high in automatic degree, high in device modularization and simple and effective in gastrointestinal peristalsis mode simulation.

The invention provides remote target locating method and system based on a dual-magnetic field sensor array plane. The system comprises an object required to be located, a magnetic sensor array, a magnetic field space analysis device and a background magnetic field compensation sensor. The invention provides the remote target locating method and system based on the dual-magnetic field sensor array plane; a target area is between two magnetic field sensor array planes; a point with the strongest field intensity in the two planes is found out, and then the remote target can be located by utilizing physical and mathematical knowledge combined with magnetic field compensation information. The method is not only suitable for an open environment, but also is suitable for a closed environment, such as a human digestive system, a liquid processing pipeline or some mechanical systems. According to the method, the defects of traditional remote locating are abandoned, and the method has the advantages that the location is accurate, the cost is low, the efficiency is high and the calculation is simple.

An energetic or nutritive composition includes at least one compound having laxative properties, mineral salts (or electrolytes) such as sodium, potassium, chlorine, calcium, magnesium, phosphor. The composition may also include carbohydrates that may be assimilated by the human digestive system such as glucose, galactose, fructose, maltose, saccharose, polysaccharides.

The invention discloses weight reducing tea. The weight reducing tea is prepared from the following Chinese medicinal materials in parts by weight: 50 parts of black tea, 20 parts of cortex albiziae, 10 parts of Chinese date, 2 parts of isatis root, 2 parts of honeysuckle, 2 parts of dandelion, 2 parts of houttuynia cordata, 2 parts of selfheal, 2 parts of christina loosestrife herb, 2 parts of patrinia, 2 parts of Chinese pulsatilla root, 2 parts of folium isatidis, 2 parts of herba eupatorii and 2 parts of asarum. The weight reducing tea is safe and reliable, produces no damage or side effect to a digestive system and an absorption system of a human body, promotes normal metabolism of the human body by replenishing qi and blood and also has an effect of reducing cholesterol and blood fat and an obvious weight reducing effect, weight hardly can regain after the weight reducing tea is not drunk, and raw materials of the weight reducing tea are cheap and easily available, so that the weight reducing tea has the advantage of low cost and is applicable to market promotion.

The invention discloses a rat-pig intestinal epithelial cell integrated model established by lipopolysaccharide (LPS) stimulation. Bacterial lipopolysaccharide (LPS) has a function in damaging intestinal epithelial barrier, and the integrated model disclosed by the invention aims at identifying whether an antimicrobial peptide Cathelicidin-BF (C-BF) derived from a snake has a protective effect on LPS-induced enteritidis or not. IPEC-J2 is an intestinal epithelial cell line isolated from the porcine jejunum segment and the porcine digestive system is very similar to the human digestive system. By in vivo rat model and in vitro porcine IPEC-J2 cell model, the protective effect of Cathelicidin-BF on impaired LPS-induced intestinal barrier function is tested. The test results show that the Cathelicidin-BF has protective effects on impaired LPS-induced intestinal barrier function and LPS-induced IPEC-J2 cell damage model.

A bionic digestion determination method for the total quantity of digestible carbohydrates of feed includes the following steps that 1, sample preparation is carried out; 2, a buffer solution and simulated digestive juice of the stomach and the small intestine and other reagents are prepared; 3, a monogastric animal bionic digestive system is preheated; 4, sample loading is carried out; 5, stomach simulated digestion treatment is carried out; 6, small intestine simulated digestion treatment is carried out, wherein small intestine simulated digestion parameters are set through monogastric animal bionic digestive system control software, and small intestine simulated digestion treatment is started; 7, digestion residue treatment is carried out; 8, the content of reducing sugar in a control sample and the content of reducing sugar in an analysis sample are determined with the DNS colorimetric method, and the total quantity of digestible carbohydrates of the feed is worked out. According to the bionic digestion determination method for the total quantity of digestible carbohydrates of the feed, the external digestion process is automatically controlled in the monogastric animal bionic digestive system, and the test result is high in reproducibility and precision; the workload of operators is reduced, system errors caused by manual operation are eliminated, and the detection efficiency is high.

A dietary supplement which is formulated for medical patients, particularly cancer patients undergoing a chemotherapy treatment regimen. The ingredients are formulated in a form which is easiest for the patient to digest, with consideration of the damage that chemotherapy causes to the digestive system. The dietary supplement provides an ample and well-balanced source of essential and non-essential amino acids, as well as vitamins and minerals. The amino acids are preferably provided in the form of free amino acids, which can be directly absorbed into the bloodstream without digestion. The supplement is formulated in such a manner that it can be used as the sole nutritional source for substantial periods of time.

The invention relates to a traditional Chinese medicine compound preparation which is anti-ulcer and capable of alleviating toxic and side effects of radiotherapy and chemotherapy, and its preparation method and application. 3-10 parts of Scutellaria baicalensis, the above four herbs form the basic formula, supplemented with one or more of the following traditional Chinese medicines by weight: 5-15 parts of ginseng, 20-35 parts of astragalus, 3-15 parts of licorice, jujube 5 to 18 pieces. The present invention is a compound preparation obtained by screening prescriptions based on many years of clinical experience and optimizing the preparation process according to the theory of traditional Chinese medicine. This prescription has the effects of nourishing qi and harmonizing the stomach, combining cold and heat, dispelling mass and resolving stagnation, etc. It can be widely used in digestive system diseases such as ulcer disease, chronic gastritis, Helicobacter pylori gastropathy, enteritis, etc. The role of its definite curative effect, rapid effect, no toxic side effects.

The ulcer treating medicine is prepared with Dangshen, white atractylodes rhizome, bupleurum root, fingered citron, roasted licorice and other nine kinds of Chinese medicinal materials. It regulates, treats, repairs and protects stomach and duodenum comprehensively through benefiting vital energy, promoting blood circulation, repairing and protecting membrane, sterilizing, etc. It has fast acting, short treating course, high curative effect, and low cost.

The present invention provides a human digestive system health risk early-warning system. The system comprises: a human health scanning system, which is used for scanning and evaluating function values of tissues and organs in a human digestive system; a digestive system health risk early-warning data processor, which is used for acquiring clinical index data of the digestive system, and by virtue of a human digestive system health risk early-warning model, carrying out human digestive system health risk early-warning on the basis of the function values of the tissues and the organs in the human digestive system and the clinical index data of the digestive system; and a digestive system health risk early-warning result display, which is used for displaying a digestive system health risk early-warning result, wherein the output end of the human health scanning system is connected to the input end of the digestive system health risk early-warning data processor, and the output end of the digestive system health risk early-warning data processor is connected to the digestive system health risk early-warning result display. According to the human digestive system health risk early-warning system, potential risk factors and a disease development direction can be predicted, and early warning of human digestive system health risks can be realized.

A coated smooth surface of a substrate repels liquids and viscoelastic materials and can have anti-staining and anti-biofouling properties. The smooth surface can be coated by applying a chemical layer on the surface and a lubricant. Such coated surfaces are useful for use in toilets, urinals, or other devices for the processing of liquids and viscoelastic materials such as solid or semi-solid metabolic waste of human digestive system. Such coated surfaces can also be applied to windows for buildings or vehicles such as automobiles or camera lenses to repel liquids (e.g., rain), ice, frost, insect residues, and birds' feces.

The invention discloses a dynamic human stomach-duodenum in-vitro bionic digestive system comprising a heating incubator and an esophagus model, a stomach model, a duodenum model, peristaltic extrusion devices and a digestion emptying unit which are located in the heating incubator, and the esophagus model, the stomach model and the duodenum model are connected with one another; the peristaltic extrusion devices are arranged on the two sides of the esophagus model, the stomach model and the duodenum model respectively and used for achieving bionic movement of the esophagus model, the stomach model and the duodenum model; and the digestion emptying unit comprises a feeding device connected with an inlet of the esophagus model, a digestive juice adding device connected with the stomach modeland the duodenum model, and an emptying device connected with an outlet end of the duodenum model. According to the dynamic human stomach-duodenum in-vitro bionic digestive system in the invention, the digestive process of the stomach and the duodenum of a human body can be truly simulated, accurate test data is provided for researching the digestive system of the human body, and meanwhile animalexperiments and human body experiments can be properly reduced to a certain extent.

The invention relates to a biomarker captured on a surface matrix adsorbed with an antibody group, which is detected by a quantitative mass spectrum analysis under the control of standard quality control serum. The definition of immunomic mass spectrometry analysis, namely IMS, is a method which combines a group of various antibodies with a spectrometry to accurately identify a variant or modified biomarker group. A plurality of biomarkers can be captured on one antibody group matrix at the same time, and a spectrometry accurate analysis is processed to the captured variant or modified biomarker. The invention can detect a plurality of biomarker groups at the same time. The method of the invention can be used for detecting a biomarker combination in fluid which is separated from a human body. The biomarker combination is applicable to the detection method of a kit which identifies in vitro fluid of a normal person and patients with different types of tumours of the digestive system. The method is accurate, convenient and rapid.